Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma.
<h4>Background</h4>We undertook a study to evaluate the clinical relevance of miR-92a in plasma obtained from non-Hodgkin's lymphoma (NHL) patients, because the miR-17-92 polycistronic miRNA cluster plays a crucial role in lymphomagenesis and affects neo-angiogenesis.<h4>Metho...
Guardado en:
Autores principales: | Kazuma Ohyashiki, Tomohiro Umezu, Sei-Ichiro Yoshizawa, Yoshikazu Ito, Michiyo Ohyashiki, Hisashi Kawashima, Masami Tanaka, Masahiko Kuroda, Junko H Ohyashiki |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e6082c2af40a4251a0de894f087ed976 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients.
por: Masami Tanaka, et al.
Publicado: (2009) -
Epigenetic Regulation of miR-92a and TET2 and Their Association in Non-Hodgkin Lymphoma
por: Esther K. Elliott, et al.
Publicado: (2021) -
Hodgkin's lymphoma
por: E. A. Demina, et al.
Publicado: (2020) -
Current advances in Hodgkin’s lymphoma
por: Joseph Vadakara, et al.
Publicado: (2019) -
MEDICAL TREATMENT IN HODGKIN LYMPHOMA
por: Nilgun Kurucu
Publicado: (2021)